Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIV - A Type II Hybrid Implementation-Effectiveness Study

NCT03210701 is registered in ClinicalTrials.gov with Memorial University of Newfoundland as lead sponsor.

NCT NCT03210701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03210701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIV - A Type II Hybrid Implementation-Effectiveness Study
Lead sponsor
Memorial University of Newfoundland
Phase
Not applicable
Overall status
Completed
Start date
February 14, 2017
Completion date
September 1, 2017
Enrollment
123 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections